04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
Your company has just made its largest acquisition ever and your CEO says they want you to have a co...
Read More >
For a little over a year, California employers and courts have been wrestling with the impact of Dyn...
Read More >
In 2019, the U.S. Court of Appeals for the Second Circuit made headlines when it ruled that creditor...
Read More >
In communications with other plan providers, clients, and potential clients, you have to be clear. T...
Read More >
In response to complaints from the trucking industry, on August 14 the federal Department of Transpo...
Read More >
In Fort Bend County, Texas v. Davis, 139 S. Ct. 1843 (2019), the Supreme Court of the United States ...
Read More >